Sector Update: Healthcare Shares Mixed Pre-Market; Progenics Reports Better-Than-Expected Net Loss

By
A A A

Healthcare stocks:

JNJ: +0.27%

PFE: -0.26%

ABT: flat

MRK: -0.41%

AMGN: flat

Healthcare shares are flat to higher in pre-market, while Progenics Pharmaceuticals ( PGNX ) reported a Q3 loss of $0.17 per share, versus the Capital IQ consensus of $0.22 per share. Revenues were $0.87 million, versus the analyst estimate of $1.87 million.

In the same period last year, the company reported $0.33 loss per share on revenues of $1.1 million.

And, Immunogen ( IMGN ) was Novartis ( NVS ) has licensed the exclusive right to use its antibody-drug conjugate technology to develop anticancer therapeutics to an undisclosed target. IMGN last matched down 4.18% in pre-market trade. NVS is flat in pre-market trade.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: IMGN , NVS , PGNX

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

79,812,121
  • $12.11 ▼ 5.61%
68,370,136
  • $104.83 ▲ 1.79%
65,036,978
  • $16.60 ▲ 1.22%
64,087,181
  • $8.40 ▲ 5.93%
54,443,769
  • $33.66 ▼ 2.43%
44,944,529
  • $97.82 ▲ 1.50%
40,119,778
  • $45.02 ▲ 1.44%
34,306,166
  • $80.04 ▲ 2.13%
As of 10/23/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com